Our data strongly suggested the possibility of an aberrant GDF-15 expression occurring in all malignant thyroid tumors included in the study, with the expression being strikingly higher in CPTC and FVPTC than in FTC, though statistically not of much help in differentiating among them. The gene discussed is GDF15; the disease is thyroid cancer, nonmedullary, 2.